Papers
6
Total Citations
92
H-Index
6
About
Dr. Hanbo Pan is a leading thoracic surgeon whose research focuses on optimizing surgical outcomes for non-small cell lung cancer (NSCLC) patients, particularly through the comparative analysis of robotic-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS). His major contributions lie in defining the benefits of robotic surgery across diverse, high-risk populations—including octogenarians, patients aged 75 and older, young adults (≤35 years), and those receiving neoadjuvant immunochemotherapy. Notably, his propensity score-matched studies, such as the 2022 work comparing RATS, VATS, and open lobectomy in elderly patients (26 citations), and the 2023 analysis of sub-lobar resection in octogenarians (17 citations), have provided critical real-world evidence on perioperative safety and oncological efficacy. Dr. Pan also investigates lymph node dissection quality and early recurrence patterns, as seen in his 2024 study from an eleven-year high-volume center dataset. With over 90 total citations across his most-cited works, his research is instrumental in guiding surgical decision-making for NSCLC, demonstrating that robotic approaches can offer superior outcomes in specific patient subgroups.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6